Sigilon CEO and Key Executive Team

• Rogerio Vivaldi

  President, Chief Executive Officer and Director
• Philip Ashton-Rickardt

  Chief Scientific Officer
• Sarah Yuan

  Chief Technical Operations Officer
• Matthew Kowalsky

  Chief of Staff, Chief Legal and Administrative Officer and Secretary
• Melodie Henderson

  Vice President, Intellectual Property Counsel
• Olivia G. Kelly

  SVP, Head of Diabetes Research
• Josias Pontes

  Chief Financial Officer
• Robert Ruffolo

  Director
• Bernd Kullmann

  SVP, Head of Operations and Project Management
• Kerry Gagnon

  VP, Quality
• Joseph Tumang

  VP, Immunology and Preclinical Development
• Jiang Wu

  VP, Head of Bioanalytical & CMC Analytical Development
• Jamie Murphy

  VP, Finance & Controller
• Doug Cole

  Chairman
• John Cox

  Director
• Eric Shaff

  Director
• Robert Windsor

  VP, Head of Investor Relations
• Roger Harrington

  VP, Process Development
• Stephen Oesterle

  Director
• Kavita Patel

  Director
• Daniel G. Anderson

  Co-Founder
• Robert Langer

  Co-Founder
• José Oberholzer

  Co-Founder
• Arturo Vegas

  Co-Founder
• Omid Veiseh

  Co-Founder
• Ying Jing

  VP, Process Development

Source: sigilon.com, sigilon.com, sigilon.com